Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Vial

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Hypertension|March 1, 1989
Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in ratsJ H Vial, G W Boyd
The Medical Journal of Australia|February 6, 1998
Graduates of the University of Tasmania Medical School: career achievements 10 to 23 years after graduationJ H Vial, H K Muller
Internal Medicine Journal|July 18, 2001
Adverse drug events as a cause of hospital admission in the elderlyM Chan, F Nicklason, J H Vial
Journal of Hypertension|February 1, 1989
Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and preventionJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|December 1, 1991
Delayed recovery from NG-nitro-L-arginine in the conscious sheepC K Narkowicz, J H Vial, X F Xu
Free Radical Research Communications|January 1, 1993
Hyperbaric oxygen therapy increases free radical levels in the blood of humansC K Narkowicz, J H Vial, P W McCartney
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the ratJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|May 1, 1983
Prevention of structural arteriolar changes in DOCA hypertension with hydrallazineJ H Vial, A C Yong, G W Boyd
Internal Medicine Journal|January 11, 2002
Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke preventionG M Peterson, K Boom, S L Jackson, et al.
Australian and New Zealand Journal of Medicine|October 1, 1990
Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirinJ H Vial, L J McLeod, M S Roberts, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Hypertension|March 1, 1989
Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in ratsJ H Vial, G W Boyd
The Medical Journal of Australia|February 6, 1998
Graduates of the University of Tasmania Medical School: career achievements 10 to 23 years after graduationJ H Vial, H K Muller
Internal Medicine Journal|July 18, 2001
Adverse drug events as a cause of hospital admission in the elderlyM Chan, F Nicklason, J H Vial
Journal of Hypertension|February 1, 1989
Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and preventionJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|December 1, 1991
Delayed recovery from NG-nitro-L-arginine in the conscious sheepC K Narkowicz, J H Vial, X F Xu
Free Radical Research Communications|January 1, 1993
Hyperbaric oxygen therapy increases free radical levels in the blood of humansC K Narkowicz, J H Vial, P W McCartney
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the ratJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|May 1, 1983
Prevention of structural arteriolar changes in DOCA hypertension with hydrallazineJ H Vial, A C Yong, G W Boyd
Internal Medicine Journal|January 11, 2002
Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke preventionG M Peterson, K Boom, S L Jackson, et al.
Australian and New Zealand Journal of Medicine|October 1, 1990
Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirinJ H Vial, L J McLeod, M S Roberts, et al.
Pageof 3